Phase II Study of Cisplatin, Ifosfamide . Paclitaxel (CIP) as Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Carcinoma.

Search: Korean J Obstet Gynecol Search

CLOSE

Original Article

Korean Journal of Obstetrics & Gynecology 2000;43(10):1763-1768.
Published online January 1, 2001.

Phase II Study of Cisplatin, Ifosfamide . Paclitaxel (CIP) as Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Carcinoma.

Seog Beom Yoon, Jong Kug Lee, Seob Jeon, Ji Yeon Lee, Seung Do Choi, Dong Han Bae

Abstract

No abstract available.

TOOLS

Full text via DOI
Download Citation

Share :

METRICS

640 View
10 Download

Related articles in Obstet Gynecol Sci

The Effect of Neoadjuvant Chemotherapy in Uterine Cervical Cancer.1997 February;40(2)

A Clinical Study of Multiple Primary Malignancies in Patients Treated for Cervical Carcinoma.1997 September;40(9)

Implication of Neoadjuvant Chemotherapy for the Management of Patients with Locally Advanced Cervical Cancer.2000 August;43(8)

Neoadjuvant Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer.2004 April;47(4)

Phase II Study of CP (Cisplatin/Paclitaxel) as Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Carcinoma.2005 March;48(3)

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2266-7238 Fax: +82-2-3445-2440 E-mail: journal@ogscience.org

Copyright © 2024 by Korean Society of Obstetrics and Gynecology.

prev

next